Skip to content

Clinical trials

Phase 3 Inflammation trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 3 Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20101
20122
20131
20171
20212
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Alloksys Life Sciences B.V.1
Amsterdam UMC, location VUmc1
AstraZeneca1
Novo Nordisk A/S1
Population Health Research Institute1
UMC Utrecht1
W.G.Boersma1
aTyr Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation13
Asthma2
Sepsis2
Alzheimer Disease1
Angioedemas, Hereditary1
Aortic Valve Disease1
Aortic Valve Stenosis1
Atherosclerosis1
Bronchial Diseases1
Bronchiectasis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.